Patents by Inventor Larry T. Mimms

Larry T. Mimms has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hepatitis B virus mutants, reagents and methods for detection
    Patent number: 5925512
    Abstract: Mutant Hepatitis B Virus (HBV) nucleic acid sequences useful for a variety of diagnostic and therapeutic applications, kits for using the HBV nucleic acid sequences, HBV immunogenic particles, and a method for producing antibodies to HBV. Also provided are methods for producing antibodies, polyclonal or monoclonal, from the HBV nucleic acid sequences.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: July 20, 1999
    Assignee: Abbott Laboratories
    Inventors: William F. Carman, Richard H. Decker, Lesley Wallace, Larry T. Mimms, Larry R. Solomon
  • Monoclonal antibodies to hepatitis C virus and method for using same
    Patent number: 5753430
    Abstract: Monoclonal antibodies which specifically bind to either Hepatitis C Virus C-100 protein, Hepatitis C Virus 33C protein and Hepatitis C Virus CORE protein, and hybridomas which produce these monoclonal antibodies. Also provided are methods for using these monoclonal antibodies and assay kits containing these antibodies.
    Type: Grant
    Filed: September 29, 1994
    Date of Patent: May 19, 1998
    Assignee: Abbott Laboratories
    Inventors: Smriti U. Mehta, Jill Johnson, Sheela M. George, Suresh M. Desai, Larry T. Mimms, Sushil G. Devare, Joan D. Tyner, Mary S. Gibadlo
  • Hepatitis B virus mutants, reagents and methods for detection
    Patent number: 5595739
    Abstract: Mutant Hepatitis B Virus (HBV) nucleic acid sequences useful for a variety of diagnostic and therapeutic applications, kits for using the HBV nucleic acid sequences, HBV immunogenic particles, and a method for producing antibodies to HBV. Also provided are methods for producing antibodies, polyclonal or monoclonal, from the HBV nucleic acid sequences.
    Type: Grant
    Filed: May 7, 1993
    Date of Patent: January 21, 1997
    Assignee: Abbott Laboratories
    Inventors: William F. Carman, Richard H. Decker, Lesley Wallace, Larry T. Mimms, Larry R. Solomon
  • Hepatitis B virus mutants, reagents and methods for detection
    Patent number: 5593825
    Abstract: Mutant Hepatitis B Virus (HBV) nucleic acid sequences useful for a variety of diagnostic and therapeutic applications, kits for using the HBV nucleic acid sequences, HBV immunogenic particles, and a method for producing antibodies to HBV. Also provided are methods for producing antibodies, polyclonal or monoclonal, from the HBV nucleic acid sequences.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: January 14, 1997
    Assignee: Abbott Laboratories
    Inventors: William F. Carman, Richard H. Decker, Lesley Wallace, Larry T. Mimms, Larry R. Solomon
  • Hepatitis B Virus mutants, reagents and methods for detection
    Patent number: 5591440
    Abstract: Mutant Hepatitis B Virus (HBV) nucleic acid sequences useful for a variety of diagnostic and therapeutic applications, kits for using the HBV nucleic acid sequences, HBV immunogenic particles, and a method for producing antibodies to HBV. Also provided are methods for producing antibodies, polyclonal or monoclonal, from the HBV nucleic acid sequences.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: January 7, 1997
    Assignee: Abbott Laboratories
    Inventors: William F. Carman, Richard H. Decker, Lesley Wallace, Larry T. Mimms, Larry R. Solomon
  • Immunoassays using antigens produced in heterologous organisms
    Patent number: 5254458
    Abstract: This invention relates to improved "sandwich" immunoassays for antibodies in body fluids of the type where antigen specific for the antibody to be detected is disposed on a solid support and binds antibody from the body fluid, from which the antibody bound to the solid support is detected by a labeled antigen to the antibody to be detected. The improvement comprises using antigens from heterologous cell sources.
    Type: Grant
    Filed: July 29, 1992
    Date of Patent: October 19, 1993
    Assignee: Abbott Laboratories
    Inventor: Larry T. Mimms